A Phase I Study of Chimeric Anti-Phosphatidylserine Monoclonal Antibody (Tarvacin™) in Patients Chronically Infected with Hepatitis C Virus (HCV) who are Non-responders or Relapsers after Treatment with Pegylated Interferon plus Ribavirin
Karen Roberts, MS 714.508.6035 ***@****
PHASE I STUDY SITE
Bach & Godofsky, MD, PA, Bradenton, Florida, 34205, United States; Recruiting
Mickey Mays, RNMS, ARNP 941-746-2711 Ext.